AU5652799A - Method for the diagnosis of cell proliferative disease - Google Patents

Method for the diagnosis of cell proliferative disease

Info

Publication number
AU5652799A
AU5652799A AU56527/99A AU5652799A AU5652799A AU 5652799 A AU5652799 A AU 5652799A AU 56527/99 A AU56527/99 A AU 56527/99A AU 5652799 A AU5652799 A AU 5652799A AU 5652799 A AU5652799 A AU 5652799A
Authority
AU
Australia
Prior art keywords
diagnosis
cell proliferative
proliferative disease
disease
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56527/99A
Inventor
Yoshimi Homma
Noritaka Oyama
Koichiro Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU5652799A publication Critical patent/AU5652799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/331—Methylation site specific nuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU56527/99A 1998-09-18 1999-09-17 Method for the diagnosis of cell proliferative disease Abandoned AU5652799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26508998 1998-09-18
JP10/265089 1998-09-18
PCT/JP1999/005069 WO2000017339A1 (en) 1998-09-18 1999-09-17 Method for the diagnosis of cell proliferative disease

Publications (1)

Publication Number Publication Date
AU5652799A true AU5652799A (en) 2000-04-10

Family

ID=17412454

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56527/99A Abandoned AU5652799A (en) 1998-09-18 1999-09-17 Method for the diagnosis of cell proliferative disease

Country Status (5)

Country Link
US (2) US6699666B1 (en)
EP (1) EP1114860A4 (en)
AU (1) AU5652799A (en)
CA (1) CA2343078A1 (en)
WO (1) WO2000017339A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076630A1 (en) * 2000-04-06 2001-10-18 Kyowa Hakko Kogyo Co., Ltd. Diagnostics and remedies for rheumatoid arthritis
WO2002010368A1 (en) * 2000-07-21 2002-02-07 Chiba Prefecture Tumor-specific promoters
WO2007081791A2 (en) * 2006-01-04 2007-07-19 The Johns Hopkins University Compare-ms:method rapid, sensitive and accurate detection of dna methylation
SG2014011316A (en) 2011-08-31 2014-06-27 Genentech Inc Diagnostic markers
WO2017027519A1 (en) * 2015-08-11 2017-02-16 Apocell, Inc. Systems and methods for isolating target particles and their use in diagnostic, prognostic, and therapeutic, methods
IL271215B2 (en) * 2017-06-07 2025-02-01 Univ Oregon Health & Science Single cell whole genome libraries for methylation sequencing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912141A (en) 1996-05-22 1999-06-15 President & Fellows Of Harvard College Nucleic acids encoding tumor virus susceptibility genes
WO1998000552A2 (en) 1996-07-02 1998-01-08 President And Fellows Of Harvard College Receptor tyrosine phosphatase, and uses related thereto
WO1998040487A1 (en) 1997-03-14 1998-09-17 The Endowment For Research In Human Biology, Inc. Angiogenin receptor, compositions and methods related thereto
AU8778698A (en) 1997-08-11 1999-03-01 Ontogeny, Inc. Serine/threonine kinase, and uses related thereto
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor

Also Published As

Publication number Publication date
WO2000017339A1 (en) 2000-03-30
EP1114860A1 (en) 2001-07-11
CA2343078A1 (en) 2000-03-30
US6699666B1 (en) 2004-03-02
EP1114860A4 (en) 2002-12-18
US20040214207A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
AU2779799A (en) Process for producing an electrochemical biosensor
AU5324099A (en) Methods for predicting drug response
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
IL142938A0 (en) Microbiological method for the preparation of an epothilone
AU3412799A (en) Method for the preparation of organic carbamates
AU4787899A (en) Methods, apparatuses and imaging mode for tomographic imaging
AU6372099A (en) Method for the generation of dna fingerprints
AU2308900A (en) Analysis method
AU3444899A (en) Method for the rapid determination of bacteria
AU6105199A (en) Diagnostic method
AU5449099A (en) Novel receptor protein and method for diagnosing inflammatory diseases by using the same
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU5652799A (en) Method for the diagnosis of cell proliferative disease
AU1163101A (en) Diagnostic methods
AU6484599A (en) An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
AU1704000A (en) Method for diagnostic screening
AU5621399A (en) Method for measuring the movements of the heart
AU6509698A (en) Methods for clinical diagnosis
AU6634298A (en) Biosensor for cells
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AUPP612798A0 (en) Diagnostic method
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU5830400A (en) Diagnostic method for squamous cell carcinoma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase